Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human IL22/IL-21/IL-22 ORF/cDNA clone-Adenovirus particle (NM_020525)
Cat. No.: vGMAP-IL-112
Pre-made Human IL22/IL-21/IL-22 Adenovirus for IL22 overexpression in-vitro and in-vivo. The IL22 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified IL22-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
IL-22/IL22/IL22/IL-21 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
MSDS
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP-IL-112 | Human IL22 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP-IL-112 |
| Gene Name | IL22 |
| Accession Number | NM_020525 |
| Gene ID | 50616 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 540 bp |
| Gene Alias | IL-21,IL-22,IL-D110,IL-TIF,ILTIF,TIFa,TIFIL-23,zcyto18 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGGCCGCCCTGCAGAAATCTGTGAGCTCTTTCCTTATGGGGACCCTGGCCACCAGCTGCCTCCTTCTCTTGGCCCTCTTGGTACAGGGAGGAGCAGCTGCGCCCATCAGCTCCCACTGCAGGCTTGACAAGTCCAACTTCCAGCAGCCCTATATCACCAACCGCACCTTCATGCTGGCTAAGGAGGCTAGCTTGGCTGATAACAACACAGACGTTCGTCTCATTGGGGAGAAACTGTTCCACGGAGTCAGTATGAGTGAGCGCTGCTATCTGATGAAGCAGGTGCTGAACTTCACCCTTGAAGAAGTGCTGTTCCCTCAATCTGATAGGTTCCAGCCTTATATGCAGGAGGTGGTGCCCTTCCTGGCCAGGCTCAGCAACAGGCTAAGCACATGTCATATTGAAGGTGATGACCTGCATATCCAGAGGAATGTGCAAAAGCTGAAGGACACAGTGAAAAAGCTTGGAGAGAGTGGAGAGATCAAAGCAATTGGAGAACTGGATTTGCTGTTTATGTCTCTGAGAAATGCCTGCATTTGA |
| ORF Protein Sequence | MAALQKSVSSFLMGTLATSCLLLLALLVQGGAAAPISSHCRLDKSNFQQPYITNRTFMLAKEASLADNNTDVRLIGEKLFHGVSMSERCYLMKQVLNFTLEEVLFPQSDRFQPYMQEVVPFLARLSNRLSTCHIEGDDLHIQRNVQKLKDTVKKLGESGEIKAIGELDLLFMSLRNACI |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-209 | Pre-Made Fezakinumab biosimilar, Whole mAb, Anti-IL22 Antibody: Anti-IL-21/IL-22/IL-D110/IL-TIF/ILTIF/TIFIL-23/TIFa/zcyto18 therapeutic antibody |
| Target Antibody | GM-Tg-g-T44682-Ab | Anti-IL22/ IL-21/ IL-22 functional antibody |
| Target Antigen | GM-Tg-g-T44682-Ag | IL22 protein |
| Cytokine | cks-Tg-g-GM-T44682 | Interleukin 22 (IL22) protein & antibody |
| ORF Viral Vector | pGMLP002305 | Human IL22 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-IL-029 | Human IL22 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-IL-112 | Human IL22 Adenovirus plasmid |
| ORF Viral Vector | vGMLP002305 | Human IL22 Lentivirus particle |
| ORF Viral Vector | vGMLP-IL-029 | Human IL22 Lentivirus particle |
| ORF Viral Vector | vGMAP-IL-112 | Human IL22 Adenovirus particle |
Target information
| Target ID | GM-T44682 |
| Target Name | IL-22/IL22 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
50616 |
| Gene ID |
100058976 (Equus caballus), 101095184 (Felis catus), 481153 (Canis lupus familiaris), 500836 (Rattus norvegicus) 50616 (Homo sapiens), 507778 (Bos taurus), 718047 (Macaca mulatta) |
| Gene Symbols & Synonyms | IL22,Il22,IF2B1,If2b1,RGD1561292,TIFa,IL-21,IL-22,ILTIF,IL-TIF,IL-D110,zcyto18,TIFIL-23 |
| Target Alternative Names | Cytokine Zcyto18,IF2B1,IL-10-related T-cell-derived-inducible factor (IL-TIF),IL-21,IL-22,IL-D110,IL-TIF,IL22,ILTIF,If2b1,Il22,Interleukin-22,RGD1561292,TIFIL-23,TIFa,zcyto18 |
| Uniprot Accession |
Q9GZX6
Additional SwissProt Accessions: Q9GZX6 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index, Cytokine Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Th17 cell differentiation, Inflammatory bowel disease |
| Gene Ensembl | ENSECAG00000019526, ENSCAFG00845013728, ENSG00000127318, ENSBTAG00000015407, ENSMMUG00000018724 |
| Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.